+ 44 (0)20 8332 2588

ReCode Therapeutics is a US-based, clinical-stage genetic medicines company is developing therapeutics for genetically defined diseases with no existing treatment options including primary ciliary dyskinesia and cystic fibrosis.

Erytech Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, best known for its proprietary ERYCAPS® red cell encapsulation platform, which it uses to produce red cell-based therapeutics to treat patients with rare forms of cancer and orphan diseases. Erytech’s lead product candidate, eryaspase (red cells encapsulating asparaginase), is currently in Phase 3 […]

DemeRx is a US-based clinical stage pharmaceutical development company advancing drug candidates as therapies for addiction. It is currently evaluating patient data which demonstrate that a single dose of ibogaine may be sufficient to detoxify opioid-dependent persons and diminish drug cravings for extended time periods. As part of their clinical plan, DemeRx is evaluating the […]

Cleothena Enterprises Pty Ltd. is a forward-thinking biotechnology company focused on advancing innovative therapeutic solutions through precision science, robust clinical strategy, and streamlined regulatory engagement. Specialising in the development and communication of high-quality clinical and scientific materials—such as clinical protocols, Investigator’s Brochures, and regulatory documentation—Cleothena supports biopharmaceutical organisations in accelerating their development programs with clarity, […]

The British Society for Haematology (BSH), the UK’s largest haematology organisation, promotes excellence within the field and supports the professional development of over 3000 members.

Cardionetics is an innovative hardware and software solutions company specialising in providing intelligent systems for diagnostic, monitoring, and screening purposes.

Recardio is a life science company that focuses on drug-based regenerative therapeutic modalities for treatments of cardiovascular diseases.

Surface Logix is a drug development company which uses its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic and pharmacodynamic properties compared with class leaders.

A specialist pharmaceutical company dedicated to HIV medicines and research with an extensive portfolio of prescription medicines.

Synairgen is a UK-based biopharmaceutical company focused on developing innovative treatments for respiratory diseases, particularly known for its lead product, an inhaled interferon beta (IFN-β) for severe viral lung infections.

Following the acquisition of Strimvelis and associated gene therapy assets by Orchard Therapeutics, our contributions were formally acknowledged as foundational to the success of the regulatory submission. Recognizing the depth of our experience and our commitment to scientific excellence, Orchard Therapeutics re-engaged our team to support the preparation of a new regulatory submission for an […]

Nabriva Therapeutics was incorporated as a spin-off from Sandoz GmbH Antibiotics Research Institute (ABRI) in Vienna. The new organisation included small molecule assets, including pleuromutilin structure activity relationships (SAR) knowledge, and focused on synthesis of pleuromutilins for systemic human use. Following identification of their lead compound lefamulin and based on its clinical results for acute […]

EVERSANA is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organisations, including innovative start-ups […]

Adaptimmune specialises in developing novel therapies for the treatment of resistant tumour types.

The FRAILOMIC initiative was an international research project aimed at improving the understanding, diagnosis, and management of frailty in older populations.

The RASP-UK initiative, or Refractory Asthma Stratification Programme, is a UK-based research effort designed to transform the management of severe asthma by adopting a more personalized treatment approach.

A significant European research project aimed at evaluating the impact of a multi-modal intervention on frailty and QoL in older adults.

Astex employs its proprietary Pyramid™ platform to develop innovative therapies targeting challenging or “intractable” diseases.

ApaTech was a medical device company that was involved in the manufacturing of orthobiologics, specifically the development of synthetic bone graft materials to enhance bone repair and regeneration.

Assign’s business model relied on bespoke service providers like Niche to deliver essential aspects of their business delivery model.

BioKinetic Europe was a fully integrated clinical research organisation with its own purpose-designed clinical pharmacology unit.

A 30 person not for profit biotech focused exclusively on discovering superior therapeutics for the treatment of cystic fibrosis.

Funxional Therapeutics Ltd was a privately-held pharmaceutical start-up. It was set up in 2005 to commercialise the development of broad-spectrum chemokine inhibitors.

Hammersmith Medicines Research (HMR) is a fully integrated clinical research organisation with its own purpose-designed clinical pharmacology unit.

HOOKIPA Pharma is a small but ambitious company with a pioneering vision for their arenavirus platform

iOnctura is a clinical-stage biopharmaceutical company that benefited from our history with oncology indications, to consolidate an evolving study design and manage complex data outputs to present a comprehensive package.

Nanomerics’ mission is to deliver augmented medicines with improved activity and fewer associated side effects through the application of materials science.

Petrovax is a Russian biopharmaceutical company established in 1996, specializing in the research, development, and production of innovative vaccines, pharmaceuticals, and biologics.

Pulmocide is a company dedicated to developing innovative therapies for serious respiratory diseases, focusing on viral infections and acute respiratory conditions.

Respivert was a clinical-stage biopharmaceutical company that benefited from our history and experience with asthma.

Scandinavian Development Services Life Science was a leading consultancy in the Nordics with regards to regulatory guidance, design of clinical trials and expertise in biostatistics.

Sorriso is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including Crohn’s disease and ulcerative colitis. 

Thromboserin Ltd. is an ‘innovator’ research company and our mission is to focus primarily on preventing arterial thrombosis.

VectivBio has evolved from a small biotech in engaged in early development into an organisation actively planning and rapidly approaching its own submissions for global commercialisation.